Oracle to buy Phase Forward $685m

By Staff Reporter

- Last updated on GMT

Related tags: Phase forward, Medicine

IT giant Oracle will pay $685m (€507m) for eClinical solutions firm Phase Forward, significantly expanding its presence in the billion dollar contract clinical research sector.

The deal adds Phase Forward’s range of electronic data capture (EDC) and response software to Oracle’s offering, strengthening its position in a market that Forrester Research recently predicted will be worth $26bn this year

Oracle Health Sciences (OHS) manager Neil de Crescenzo acknowledged this potential, commenting that: “Phase Forward brings outstanding products and employees with significant expertise to Oracle​.”

Crescenzo also set the Phase Forward deal in a wider context, explaining that: “The life sciences and healthcare industries are converging as they seek to control costs while accelerating patient-centred innovation​.”

Since setting up the OHS unit in 2008 Oracle has been steadily building its profile in the healthcare sector with new products and, in April 2009​, the acquisition of safety and pharmacovigilance specialist Relsys.

However, while the Relsys buy built Oracle’s capacity in preclinical testing and development, Phase Forward’s strength in the more valuable clinical research market makes the deal a more significant move.

For example, Phase Forward claims its services have been used in more than 10,000 studies by both Big Pharma firms like GlaxoSmithKline (GSK) , Sanofi-Aventis and Astrazeneca and major contractors like Quintiles, Covance and Parexel.

Related news

Show more

Related products

A Winning End-to-End Solution for Oncology Studies

A Winning End-to-End Solution for Oncology Studies

Clinical Ink | 22-Feb-2021 | Technical / White Paper

Oncology clinical trials present a unique set of challenges for patients, study sites, and study sponsors. Using electronic patient reported outcomes (ePRO)...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q² Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Related suppliers

Follow us

Products

View more

Webinars